Literature DB >> 30074651

Prevalence, awareness, and treatment of depressive symptoms among the middle-aged and elderly in China from 2008 to 2015.

Qun Wang1, Wenyao Tian2.   

Abstract

INTRODUCTION: This study aimed at exploring the temporal trend of prevalence, awareness, and treatment of depressive symptoms among the middle-aged and elderly in China from 2008 to 2015, as well as depicting how many respondents suffered from persistent depression, whether they were aware of and how they coped with such persistent conditions over time.
METHODS: This study used the 2008, 2011, 2012, 2013, and 2015 data of China Health and Retirement Longitudinal Study. We used descriptive statistics for data analysis.
RESULTS: The prevalence of depressive symptoms among the middle-aged and elderly in China remained relatively stable at 32% to 37% from 2008 to 2015. Only less than 5% of those with depressive symptoms were aware of their conditions and less than 2% sought care over time. We also observed that persistent depression was very severe among the respondents and most of those with persistent conditions were still not aware of nor seek any care for the symptoms.
CONCLUSION: Despite of the continuous efforts done by the Chinese government, depression in China is still in poor management. The Chinese government needs to first understand why and how the continuous government efforts do not turn into actual effects of depression management.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Chinese elderly; Chinese middle-aged; depression; prevalence, awareness, and treatment

Mesh:

Year:  2018        PMID: 30074651     DOI: 10.1002/hpm.2581

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  5 in total

1.  Prospective bidirectional associations between depression and chronic kidney diseases.

Authors:  Xiaowei Zheng; Wenyan Wu; Suwen Shen
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

2.  Visual impairment and depression in China: a 7-year follow-up study from national longitudinal surveys.

Authors:  Xiaohuan Zhao; Wenjia Liu; Bing Lu; Xinyue Zhu; Minwen Zhou; Xiaodong Sun
Journal:  BMJ Open       Date:  2022-04-27       Impact factor: 3.006

3.  Adapting the depression component of WHO Mental Health Gap Intervention Guide (mhGAP-IG.v2) for primary care in Shenzhen, China: a DELPHI study.

Authors:  Kendall Searle; Grant Blashki; Ritsuko Kakuma; Hui Yang; Shurong Lu; Baoqi Li; Yingying Xiao; Harry Minas
Journal:  Int J Ment Health Syst       Date:  2022-02-15

4.  Trends in the utilization of psychotropic medications in China from 2018 to 2021.

Authors:  Xinyan Zhang; Xiaowen Hu; Yuxuan Zhao; Christine Y Lu; Xiaoyan Nie; Luwen Shi
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

5.  Listening to the Shenzhen Primary Healthcare Context to Adapt the mhGAP-IG.v2 for the Assessment of Depression: Qualitative Workshops with Primary Healthcare Leaders.

Authors:  Kendall Searle; Grant Blashki; Ritsuko Kakuma; Hui Yang; Harry Minas
Journal:  Int J Environ Res Public Health       Date:  2022-02-23       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.